Moderna
MRNA
#464
Rank
A$76.91 B
Marketcap
A$192.65
Share price
-3.35%
Change (1 day)
421.13%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2026 (TTM): -A$4.61 Billion

According to Moderna 's latest financial reports the company's current earnings are A$2.20 Billion. In 2025 the company made an earning of -A$3.86 Billion, an increase over its 2024 earnings that were of -A$5.01 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$4.61 Billion19.7%
2025 -A$3.86 Billion-23.03%
2024 -A$5.01 Billion-8.22%
2023 -A$5.46 Billion-140.65%
2022 A$13.40 B-27.81%
2021 A$18.57 B-1911.15%
2020 -A$1.03 Billion44.7%
2019 -A$0.71 Billion28.63%
2018 -A$0.56 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.26 B-934.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$22.03 B-607.20%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
A$18.36 B-522.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-A$66.22 Million-98.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-A$0.17 Billion-96.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-A$58.31 Million-98.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$1.21 B-127.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-A$0.23 Billion-94.86%๐Ÿ‡บ๐Ÿ‡ธ USA